Wilson Sonsini Goodrich & Rosati advised Iambic on the transaction.Iambic Therapeutics announced the closing of an oversubscribed $100 million Series B financing. The round was co-led by Ascenta…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
